Compare MTW & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTW | AQST |
|---|---|---|
| Founded | 1902 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.1M | 504.0M |
| IPO Year | 1994 | 2007 |
| Metric | MTW | AQST |
|---|---|---|
| Price | $11.58 | $4.14 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $10.50 | $9.00 |
| AVG Volume (30 Days) | 186.0K | ★ 1.6M |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,240,900,000.00 | $67,430,000.00 |
| Revenue This Year | $4.73 | $10.08 |
| Revenue Next Year | $2.98 | $49.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.89 | 0.77 |
| 52 Week Low | $9.09 | $2.38 |
| 52 Week High | $15.56 | $7.55 |
| Indicator | MTW | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 47.82 |
| Support Level | $11.12 | $4.02 |
| Resistance Level | $11.65 | $4.38 |
| Average True Range (ATR) | 0.63 | 0.22 |
| MACD | -0.19 | -0.01 |
| Stochastic Oscillator | 9.48 | 14.90 |
Manitowoc Co Inc provides engineered lifting solutions. It designs and manufactures mobile telescopic cranes, tower cranes, lattice-boom crawler cranes, and boom trucks. It offers products under brand names such as Grove, Manitowoc, National Crane, Potain, Shuttlelift, and Manitowoc Crane Care. Its crane products serve dealers, rental companies, contractors, and government entities in diverse markets, including energy production/distribution and utility, petrochemical and industrial, infrastructure, and commercial/residential construction. Manitowoc has three reportable segments: the Americas, Europe and Africa, and the Middle East and Asia-Pacific. The Americas segment generates the majority of the revenue for the company.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.